AGN-190584 FDA Approval Status
FDA Approved: No
Brand name: AGN-190584
Generic name: pilocarpine
Dosage form: Ophthalmic Solution
Company: Allergan plc
Treatment for: Presbyopia
AGN-190584 (pilocarpine 1.25%) is an optimized ophthalmic solution formulation of the approved cholinergic muscarinic receptor agonist pilocarpine in development for the treatment of presbyopia.
Development Timeline for AGN-190584
| Date | Article |
|---|---|
| Feb 25, 2021 | Allergan Submits New Drug Application for Investigational AGN-190584 for the Treatment of Presbyopia |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.